2021
DOI: 10.1016/j.ijpharm.2021.121266
|View full text |Cite
|
Sign up to set email alerts
|

Mucoadhesive buccal tablets with propranolol hydrochloride: Formulation development and in vivo performances in experimental essential hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…Buccal films can be developed as immediate-release (IR) or prolonged-release (PR) formulations. Buccal films can also be used for local diseases of the oral cavity [16] as part of a preventive and specific treatment strategy for gingivitis [17] and periodontitis [18] or to obtain systemic therapeutic effect [19][20][21]. These films should have the appropriate size and thickness to be used on the buccal mucosa [15].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Buccal films can be developed as immediate-release (IR) or prolonged-release (PR) formulations. Buccal films can also be used for local diseases of the oral cavity [16] as part of a preventive and specific treatment strategy for gingivitis [17] and periodontitis [18] or to obtain systemic therapeutic effect [19][20][21]. These films should have the appropriate size and thickness to be used on the buccal mucosa [15].…”
Section: Introductionmentioning
confidence: 99%
“…Propranolol hydrochloride (PRH), a model drug used in this study, is a non-selective β-adrenergic blocker. It has been used in the therapy of cardiovascular diseases such as hypertension [21], arrhythmias [23], and many others. It can also be used to treat anxiety [24], migraine [19], and tremor [25].…”
Section: Introductionmentioning
confidence: 99%
“…the quantity of bioactive ingredient. Liquid formulations may also facilitate a faster onset of action since the bioactive ingredients are readily available in Orally disintegrating dosage solid forms (films and tablets) are of special interest, due to their acceptance in a wide range of populations, including children, elderly and other patients that may have issues with swallowing; Mucoadhesive dosage forms provide a more intimate contact with the oral mucosa and often a prolonged release of the active ingredient (Kurćubić et al, 2021). Abruzzo et al (2020) have formulated mucoadhesive buccal films for the local release and anti-inflammatory action of Lactobacillus brevis CD2.…”
Section: Formulation Of Probiotics and Postbiotics In Dosage Forms Fo...mentioning
confidence: 99%
“…19 Similarly, zein and PEO are polymers thoroughly explored for electrospinning and mucoadhesive applications. 20,21 Zein is a prolamin protein extracted from corn. 22 PEO is a synthetic polymer with hydroxyl functional groups.…”
Section: Introductionmentioning
confidence: 99%